Achillion Pharmaceuticals, Inc.
ACH-1095/GS-9525 is a novel-mechanism NS4A antagonist being developed by Achillion and Gilead for the $4B HCV market. ACH-1625 is a potent inhibitor of
HCV ...
http://www.achillion.com/...
|
Achillion to Present At Lazard Capital Markets 5th Annual ...
17, 2008 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (NasdaqGM:ACHN - News), a leader in the discovery and development of small molecule drugs to ...
http://biz.yahoo.com/pz/081117/154819.html...
|
Achillion Pharmaceuticals, Inc.
1 Aug 2007 ... Achillion has assembled a premier team of executives who have played key roles in the successful development and commercialization of over a ...
http://www.achillion.com/main.aspx?pn=ManagementTeam&fl=l...
|
Achillion Announces Private Placement Financing for up to $41.5 ...
Achillion Announces Private Placement Financing for up to $41.5 Million. - - Proceeds to Fund Expanding Pipeline of Infectious Disease Candidates ...
http://biz.yahoo.com/pz/080806/148049.html...
|
Fact Sheet
Achillion is an innovative biopharmaceutical company dedicated to .... Achillion ’s HCV approach is two-fold: First, focusing on a novel ...
http://www.achillion.com/PL/pdf/01_FactSheet.pdf...
|
Achillion Appoints Gary E. Frashier to Board of Directors ...
NEW HAVEN, Conn., April 2, 2008 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc., (NasdaqGM:ACHN - News) a leader in the discovery and development of ...
http://biz.yahoo.com/pz/080402/139357.html...
|
Achillion Pharmaceuticals, Inc.
By using the www.achillion.com Web site (the Site), you agree to the terms of the most recent version of these Terms of Use. Please read our Privacy Policy
...
http://www.achillion.com/main.aspx?pn=TermsOfUse...
|
Data From Achillion's Antibacterial and HIV Programs Presented At ...
Data From Achillion's Antibacterial and HIV Programs Presented At the 2008 ICAAC /IDSA Joint Meeting. - Four Posters Highlight Unique Mechanism and ...
http://biz.yahoo.com/pz/081027/153080.html...
|
ACH-1095
Achillion believes the unique mechanism of ACH-1095 may contribute to the .... ACH-1095, Achillion’s lead NS4A antagonist, also known as GS-9525, ...
http://www.achillion.com/PL/pdf/06_ns4a_bg_2.pdf...
|
AIDSinfo - HIV/AIDS Drug Information - Elvucitabine
ACH-126443 Achillion/Yale University. Curr Opin Investig Drugs. ... [3] Achillion Pharmaceuticals - Pipeline: HIV Program - Elvucitabine. ...
http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailT.aspx?int_id...
|
